150 related articles for article (PubMed ID: 34280004)
1. The
Lv F; Huang W; Wang Y
Genet Test Mol Biomarkers; 2021 Jul; 25(7):486-495. PubMed ID: 34280004
[No Abstract] [Full Text] [Related]
2. Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.
Tao MH; Cai Q; Zhang ZF; Xu WH; Kataoka N; Wen W; Xiang YB; Zheng W; Shu XO
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):943-9. PubMed ID: 17507620
[TBL] [Abstract][Full Text] [Related]
3. The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis.
Alwan AM; Afzaljavan F; Tavakol Afshari J; Homaei Shandiz F; Barati Bagherabad M; Vahednia E; Kheradmand N; Pasdar A
Mol Genet Genomic Med; 2021 Jul; 9(7):e1705. PubMed ID: 34014013
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women.
Pan Z; Fu Z; Song Q; Cao W; Cheng W; Xu X
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323034
[TBL] [Abstract][Full Text] [Related]
5. Association between rs10046, rs1143704, rs767199, rs727479, rs1065778, rs1062033, rs1008805, and rs700519 polymorphisms in aromatase (CYP19A1) gene and Alzheimer's disease risk: a systematic review and meta-analysis involving 11,051 subjects.
Song Y; Lu Y; Liang Z; Yang Y; Liu X
Neurol Sci; 2019 Dec; 40(12):2515-2527. PubMed ID: 31278540
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.
Long JR; Kataoka N; Shu XO; Wen W; Gao YT; Cai Q; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2115-22. PubMed ID: 17119036
[TBL] [Abstract][Full Text] [Related]
7. CYP19A1 rs2470152 polymorphism increases susceptibility to depression in Chinese Han population.
Yang Y; Yan H; Kong Y; Liu L; Peng Q; Wen Y; Zhou Z; Chang Q
Neurosci Lett; 2019 Nov; 713():134490. PubMed ID: 31518674
[TBL] [Abstract][Full Text] [Related]
8. Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity.
Umamaheswaran G; Kadambari D; Muthuvel SK; Kalaivani S; Devi J; Damodaran SE; Pradhan SC; Dubashi B; Dkhar SA; Adithan C
Breast Cancer Res Treat; 2020 Jul; 182(1):147-158. PubMed ID: 32385792
[TBL] [Abstract][Full Text] [Related]
9. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
[TBL] [Abstract][Full Text] [Related]
10. Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial.
Kopp TI; Jensen DM; Ravn-Haren G; Cohen A; Sommer HM; Dragsted LO; Tjonneland A; Hougaard DM; Vogel U
BMC Cancer; 2016 Apr; 16():283. PubMed ID: 27102200
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.
Fasching PA; Loehberg CR; Strissel PL; Lux MP; Bani MR; Schrauder M; Geiler S; Ringleff K; Oeser S; Weihbrecht S; Schulz-Wendtland R; Hartmann A; Beckmann MW; Strick R
Breast Cancer Res Treat; 2008 Nov; 112(1):89-98. PubMed ID: 18049890
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.
Garcia-Casado Z; Guerrero-Zotano A; Llombart-Cussac A; Calatrava A; Fernandez-Serra A; Ruiz-Simon A; Gavila J; Climent MA; Almenar S; Cervera-Deval J; Campos J; Albaladejo CV; Llombart-Bosch A; Guillem V; Lopez-Guerrero JA
BMC Cancer; 2010 Feb; 10():36. PubMed ID: 20144226
[TBL] [Abstract][Full Text] [Related]
13. [Association of CYP19A1 gene rs7176005 single nucleotide polymorphism with breast cancer risk and clinicopathologic features of tumor].
Du ZG; Wang LY; Zhou Y; Wan HY; Liang FQ; Lyu Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):827-832. PubMed ID: 30107717
[No Abstract] [Full Text] [Related]
14. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
15. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.
Han JY; Wang H; Xie YT; Li Y; Zheng LY; Ruan Y; Song AP; Tian XX; Fang WG
PLoS One; 2012; 7(11):e49296. PubMed ID: 23185313
[TBL] [Abstract][Full Text] [Related]
16. Association of ST6GAL1 and CYP19A1 polymorphisms in the 3'-UTR with astrocytoma risk and prognosis in a Chinese Han population.
Wang T; Sun Y; Xiong Z; Wu J; Ding X; Guo X; Shao Y
BMC Cancer; 2021 Apr; 21(1):391. PubMed ID: 33836687
[TBL] [Abstract][Full Text] [Related]
17. Haplotype structures and functional polymorphic variants of the drug target enzyme aromatase (CYP19A1) in South Indian population.
Umamaheswaran G; Dkhar SA; Kalaivani S; Anjana R; Revathy M; Jaharamma M; Shree KM; Kadambari D; Adithan C
Med Oncol; 2013; 30(3):665. PubMed ID: 23893151
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.
Chen C; Sakoda LC; Doherty JA; Loomis MM; Fish S; Ray RM; Lin MG; Fan W; Zhao LP; Gao DL; Stalsberg H; Feng Z; Thomas DB
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3457-66. PubMed ID: 19064562
[TBL] [Abstract][Full Text] [Related]
19. Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis.
Artigalás O; Vanni T; Hutz MH; Ashton-Prolla P; Schwartz IV
BMC Med; 2015 Jun; 13():139. PubMed ID: 26067721
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan.
Huang CS; Shen CY; Chang KJ; Hsu SM; Chern HD
Br J Cancer; 1999 Aug; 80(11):1838-43. PubMed ID: 10468307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
